AlphaFold predicted structure
MLIP · Q5VWP3

Mean pLDDT
43.3/ 100
Very low
993 residues
Confidence breakdown
- Very high(≥ 90)2%
- Confident(70–90)4%
- Low(50–70)15%
- Very low(< 50)80%
AlphaFold (Jumper et al., 2021) · CC BY 4.0
muscular LMNA interacting protein
Annotations refreshed 10 hours ago.
Diagnostic Grade (Green)
Acute rhabdomyolysis
BIALLELIC, autosomal or pseudoautosomalCongenital myopathy
BIALLELIC, autosomal or pseudoautosomalRhabdomyolysis and metabolic muscle disorders
BIALLELIC, autosomal or pseudoautosomalCardiac arrhythmias - additional genes
BIALLELIC, autosomal or pseudoautosomalmyopathy with myalgia, increased serum creatine kinase, and with or without episodic rhabdomyolysis 1
Abnormality of the skeletal system
Abnormal urine sodium concentration
heart failure
systolic heart failure
intellectual developmental disorder, autosomal dominant 64
hypertrophic cardiomyopathy
placental abruption
response to selective serotonin reuptake inhibitor
response to statin
Score is the Open Targets composite evidence score (0-1). Higher = stronger gene-disease association.
Muscular LMNA-interacting protein
Required for myoblast differentiation into myotubes, possibly acting as a transcriptional regulator of the myogenic program (By similarity). Required for cardiac adaptation to stress through integrated regulation of the AKT/mTOR pathways and FOXO1. Regulates cardiac homeostasis and plays a role in the protection against cardiac hypertrophy (By similarity). Binds chromatin (By similarity). May act as a transcriptional cofactor for ISL1, repressing its transcriptional activity (By similarity). May also repress MYOCD transcriptional activity (By similarity)
MLIP · Q5VWP3

Mean pLDDT
43.3/ 100
Very low
993 residues
Confidence breakdown
AlphaFold (Jumper et al., 2021) · CC BY 4.0